Gabriel Iobbi PhD

Gabriel has 15 years in medical device industry developing implantable, disposable, and diagnostic as well as drug combination products for venture funded to multinational medical device companies. He has led technical & interdepartmental project teams responsible for the development, regulatory approvals, and launch of innovative new products. He joined Novartis Device Development in 2013 from Maquet Cardiovascular (San Francisco, USA) where he has worked since 2008. Prior to this, he served as Technical Director of Dynamic Therapeutics (London, UK), a university research spinout. Gabriel completed his PhD in bioengineering at Imperial College London, UK, in 2007.